Congestive Heart Failure: Clinical Trials

44 trials for Congestive Heart Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

31 completed, 6 terminated, 4 unknown, 2 withdrawn. 44 Phase 3, 12 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 344Completed 31, Terminated 6, Unknown 4, Withdrawn 2, Recruiting 1
Phase 212Completed 8, Unknown 3, Withdrawn 1

Follow Congestive Heart Failure: new trials by email Literature Review of Congestive Heart Failure trials Research Report on Congestive Heart Failure

Trials (filtered) newest first · largest first

All 44 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure
Furosemide 20 Milligrams - Acute Heart Failure, Congestive Heart Failure
Phase 3RecruitingInstituto de Investigación Sanitaria Aragón1682025-03-102025-06-06
Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral Intake
OPC-61815 injection - Congestive Heart Failure
Phase 3CompletedOtsuka Pharmaceutical Co., Ltd.452019-06-172021-09-05
Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure
OPC-61815, Tolvaptan Tab 15 MG - Congestive Heart Failure
Phase 3CompletedOtsuka Pharmaceutical Co., Ltd.2942019-01-162021-08-05
Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial
Albuterol, Saline placebo - Congestive Heart Failure, Heart Failure, Left-Sided
Phase 3CompletedMayo Clinic302016-09-012019-02-22
Sub-Q Versus IV Furosemide in Acute Heart Failure
Furosemide Injection Solution (SCP-101), Furosemide Injection Solution, USP - Congestive Heart Failure
Phase 2 / Phase 3CompletedJohns Hopkins University402016-02-012017-12-18
MADIT ASIA Cardiac Resynchronization Trial
Two-lead CRT-P - Congestive Heart Failure, Left Bundle Branch Block
Phase 3TerminatedBoston Scientific Corporation12014-02-012014-04-30
Optimised Pacing Program
Enhanced standard management, Optimised heart failure management, Standard management - Pacemaker Complication, Congestive Heart Failure
Phase 3UnknownUniversity of Leeds17932013-08-012018-12-19
A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System
CardioKinetix Parachute Implant and All Appropriate Medical Therapy (AAMT) - Congestive Heart Failure, Left Ventricular (LV) Systolic Dysfunction
Phase 3TerminatedCardioKinetix, Inc3312012-12-012017-06-23
Comparative Study of Cardiopulmonary Exercise Test Land Versus Water
Aerobic and anaerobic capacity use aquatic exercises - Congestive Heart Failure
Phase 2 / Phase 3UnknownUniversity of Sao Paulo General Hospital902011-04-012011-04-28
Blood Pressure Reduction in Heart Failure
Hydralazine/amlodipine, Placebo - Heart Failure, Cardiac Failure
Phase 2 / Phase 3CompletedUniversity of Sao Paulo212011-01-012014-06-10
Safety and Efficacy of Furosemide 40mg + Amiloride Hydrochloride 10mg to Reduct Edema
Diurisa®, Lasix ® - Congestive Heart Failure
Phase 3TerminatedEurofarma Laboratorios S.A.272011-01-012022-06-03
Peritoneal Dialysis in Congestive Heart Failure
icodextrin - Congestive Heart Failure
Phase 3TerminatedMartini Hospital Groningen262010-04-012019-08-16
Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart Failure
furosemide and hypertonic saline solution, furosemide - Congestive Heart Failure, Renal Insufficiency
Phase 3CompletedAspirus Heart and Vascular Institute-Research and Education502009-11-012012-02-09
Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure
Aliskiren, Placebo - Acute Decompensated Heart Failure, Congestive Heart Failure
Phase 3CompletedNovartis Pharmaceuticals16392009-05-012013-11-07
Nebulized Albuterol for Congestive Heart Failure Exacerbation
Albuterol, Normal Saline - Congestive Heart Failure
Phase 2 / Phase 3WithdrawnUniversity of California, San Francisco2009-04-012013-10-10
Influence of Pantoprazole on Human Myocardial Contractility at Patients With Congestive Heart Failure
Pantoprazole - Congestive Heart Failure
Phase 3WithdrawnJohann Wolfgang Goethe University Hospital2008-08-012014-02-11
Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
tonapofylline, Placebo - Renal Insufficiency, Congestive Heart Failure
Phase 3CompletedBiogen4202008-07-312023-09-11
Efficiency Study of Triple-Site Cardiac Resynchronization in Patients With Heart Failure
Cardiac resynchronization pacemaker (InSync Sentry or Concerto, Medtronic, Minneapolis, MN,USA) with two intracardiac leads, Triple-site cardiac resynchronization - Congestive Heart Failure, Heart Disease
Phase 2 / Phase 3CompletedSilesian Centre for Heart Diseases1002008-02-012016-04-13
To Assess Safety and Efficacy of Myoblast Implantation Into Myocardium Post Myocardial Infarction
MyoCell, Hypothermosol - Congestive Heart Failure
Phase 2 / Phase 3UnknownBioheart, Inc.1702007-09-012017-07-21
Improving Clinician Communication Skills (ICCS)
Training Program Intervention - Advanced Cancer, Chronic Obstructive Pulmonary Disease (COPD)
Phase 3CompletedUniversity of Washington60862007-04-012014-09-16

Showing 20 of 44. Sign in to see all of them.

Narrower conditions

Heart Failure (44)  ·  Ventricular Dysfunction (4)  ·  Heart Diseases (3)  ·  Renal Insufficiency (3)  ·  Anemia (2)  ·  Cardio-Renal Syndrome (2)  ·  Cardiovascular Diseases (2)  ·  Myocardial Infarction (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Angina Pectoris (1)  ·  Atrial Fibrillation (1)  ·  Bundle-Branch Block (1)  ·  Cardiomyopathies (1)  ·  Diabetes Mellitus (1)  ·  Dyspnea (1)

Broader conditions

Cardiovascular Diseases (42)  ·  Heart Diseases (41)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Pathologic Processes (6)  ·  Vascular Diseases (5)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Lung Diseases (4)  ·  Male Urogenital Diseases (4)  ·  Respiratory Tract Diseases (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)  ·  Kidney Diseases (3)  ·  Arrhythmias, Cardiac (2)  ·  Chronic Disease (2)

Interventions

Carvedilol (3)  ·  Furosemide (3)  ·  candesartan (3)  ·  candesartan cilexetil (3)  ·  Albuterol (2)  ·  Darbepoetin alfa (2)  ·  Natriuretic Peptide, Brain (2)  ·  Sildenafil Citrate (2)  ·  Tolvaptan (2)  ·  1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine (1)  ·  Amlodipine (1)  ·  BG 9928 (1)  ·  Cardiac Resynchronization Therapy (1)  ·  Continuous Positive Airway Pressure (1)  ·  Defibrillators (1)

Sponsors

Boston Scientific Corporation (4)  ·  AstraZeneca (3)  ·  Amgen (2)  ·  Massachusetts General Hospital (2)  ·  Mayo Clinic (2)  ·  Otsuka Pharmaceutical Co., Ltd. (2)  ·  Sanofi (2)  ·  Shaddy, Robert, M.D. (2)  ·  Advanz Pharma (1)  ·  Aspirus Heart and Vascular Institute-Research and Education (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Azienda USL Reggio Emilia - IRCCS (1)  ·  Biogen (1)  ·  Bioheart, Inc. (1)  ·  Bristol-Myers Squibb (1)

Countries

United States (21)  ·  Brazil (8)  ·  Canada (8)  ·  Poland (8)  ·  Germany (7)  ·  Sweden (7)  ·  Argentina (6)  ·  France (6)  ·  Italy (6)  ·  Netherlands (6)  ·  Belgium (5)  ·  Czechia (5)  ·  Hungary (5)  ·  Romania (5)  ·  Russia (5)

Top investigators

Marc J Semigran, MD (2)  ·  Arthur J. Moss, M.D. (1)  ·  Barry A Borlaug, MD (1)  ·  Barry Greenberg, MD (1)  ·  Boris Nasseri, MD (1)  ·  Carlo Menozzi, MD (1)  ·  Chris Granger, MD (1)  ·  Christof Stamm, MD (1)  ·  Daniel Ter-Minassian, MD (1)  ·  Dr Salim Yusuf (1)  ·  Edimar A Bocchi, Prof. (1)  ·  German Larrain, MD (1)

Results publications

PMID 37366061, PMID 19196892, PMID 25326006, PMID 29431256, PMID 31370950, PMID 33301080, PMID 36632831, PMID 15152059, PMID 16230259, PMID 17384437, PMID 17384438, PMID 17848651, PMID 18279770, PMID 18549913, PMID 18565860, PMID 18992654, PMID 19001508, PMID 19204305, PMID 20008582, PMID 20090057, PMID 20142024, PMID 20154234, PMID 20231531, PMID 20435194, PMID 21068341, PMID 21123186, PMID 21199833, PMID 21292991, PMID 21350053, PMID 21606084, PMID 21693723, PMID 21715583, PMID 21750125, PMID 21805159, PMID 21875912, PMID 22064591, PMID 22093207, PMID 22267751, PMID 22651239, PMID 22887722, PMID 22893340, PMID 23351825, PMID 23478743, PMID 23487543, PMID 23537969, PMID 23743487, PMID 24302090, PMID 24497345, PMID 24626998, PMID 24649963

NIH funding

2009 (2), R01HL126638 (1), R01HL128526 (1), R01NR009987 (1), U01HL125205 (1), U10HL110262 (1)